Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model
Authors:
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 123 (2) , 172-178
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Phase I Trial of Temozolomide Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant GliomaJournal of Clinical Oncology, 2005
- Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA waferInternational Journal of Pharmaceutics, 2005
- Convection-Enhanced Drug Delivery: Increased Efficacy and Magnetic Resonance Image MonitoringCancer Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- In vivo release from a drug delivery MEMS deviceJournal of Controlled Release, 2004
- Distinct Responses of Xenografted Gliomas to Different Alkylating Agents Are Related to Histology and Genetic AlterationsCancer Research, 2004
- Molecular release from a polymeric microreservoir device: Influence of chemistry, polymer swelling, and loading on device performanceJournal of Biomedical Materials Research Part A, 2004
- Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNUJournal of Controlled Release, 1996
- Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brainBiomaterials, 1994
- Colorimetric Method for the Determination of 1,3-Bis(2-chloroethyl)-1-nitrosoureaJournal of Pharmaceutical Sciences, 1965